PAPER Tanzi RE, Kovacs DM, Kim TW, Moir RD, Guenette SY, Wasco W
SEARCH RESULTS
346774 RESULTS
PAPER Behl C, Lezoualc'h F, Trapp T, Widmann M, Skutella T, Holsboer F
Glucocorticoids enhance oxidative stress-induced cell death in hippocampal neurons in vitro.
Endocrinology. 1997 Jan;138(1):101-6. PubMed.PAPER Keilp JG, Alexander GE, Stern Y, Prohovnik I
Inferior parietal perfusion, lateralization, and neuropsychological dysfunction in Alzheimer's disease.
Brain Cogn. 1996 Dec;32(3):365-83. PubMed.PAPER Lippiello PM, Bencherif M, Gray JA, Peters S, Grigoryan G, Hodges H, Collins AC
RJR-2403: a nicotinic agonist with CNS selectivity II. In vivo characterization.
J Pharmacol Exp Ther. 1996 Dec;279(3):1422-9. PubMed.PAPER Bencherif M, Lovette ME, Fowler KW, Arrington S, Reeves L, Caldwell WS, Lippiello PM
RJR-2403: a nicotinic agonist with CNS selectivity I. In vitro characterization.
J Pharmacol Exp Ther. 1996 Dec;279(3):1413-21. PubMed.PAPER Jung SS, Nalbantoglu J, Cashman NR
Alzheimer's beta-amyloid precursor protein is expressed on the surface of immediately ex vivo brain cells: a flow cytometric study.
J Neurosci Res. 1996 Nov 1;46(3):336-48. PubMed.PAPER McDermott JR, Gibson AM
Degradation of Alzheimer's beta-amyloid protein by human cathepsin D.
Neuroreport. 1996 Sep 2;7(13):2163-6. PubMed.PAPER Kehoe P, Williams J, Holmans P, Liddell M, Lovestone S, Holmes C, Powell J, Neal J, Wilcock G, Owen MJ
Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.
Neuroreport. 1996 Sep 2;7(13):2155-8. PubMed.PAPER Shiurba RA, Ishiguro K, Takahashi M, Sato K, Spooner ET, Mercken M, Yoshida R, Wheelock TR, Yanagawa H, Imahori K, Nixon RA
Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology.
Brain Res. 1996 Oct 21;737(1-2):119-32. PubMed.PAPER van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, Narayan M, Bennett A, Delaney RC, Bronen RA, Hoffer PB
Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
J Nucl Med. 1996 Nov;37(11):1749-55. PubMed.PAPER Larson EB, Edwards JK, O'Meara E, Nochlin D, Sumi SM
Neuropathologic diagnostic outcomes from a cohort of outpatients with suspected dementia.
J Gerontol A Biol Sci Med Sci. 1996 Nov;51(6):M313-8. PubMed.PAPER Harder JA, Maclean CJ, Alder JT, Francis PT, Ridley RM
The 5-HT1A antagonist, WAY 100635, ameliorates the cognitive impairment induced by fornix transection in the marmoset.
Psychopharmacology (Berl). 1996 Oct;127(3):245-54. PubMed.PAPER Dewji NN, Singer SJ
Specific transcellular binding between membrane proteins crucial to Alzheimer disease.
Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12575-80. PubMed.PAPER Passini R, Rainville C, Marchand N, Joanette Y
Wayfinding in dementia of the Alzheimer type: planning abilities.
J Clin Exp Neuropsychol. 1995 Dec;17(6):820-32. PubMed.PAPER Pillemer K, Suitor JJ
"It takes one to help one": effects of similar others on the well-being of caregivers.
J Gerontol B Psychol Sci Soc Sci. 1996 Sep;51(5):S250-7. PubMed.Current Filters
No filters selected